See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348362_2021_Lexaria_Bioscience_Corp.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001348362, Lexaria Bioscience Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,925,961 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 483,357 |
| 3 | remainder_Assets | 418,920 |
| 4 | LiabilitiesCurrent | 225,917 |
| 5 | LiabilitiesNoncurrent | 120,063 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 78,833 |
| 8 | SellingGeneralAndAdministrativeExpense | 286,457 |
| 9 | ResearchAndDevelopmentExpense | 379,355 |
| 10 | remainder_Expenses | 3,638,652 |
| 11 | remainder_Revenues | 323,009 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,828,238 |
| 1 | Liabilities | 345,980 |
| 2 | Expenses | 4,383,297 |
| 3 | Revenues | 323,009 |
| 4 | StockholdersEquity | 2,482,258 |
| 5 | NetIncome | -4,060,288 |
| 6 | ComprehensiveNetIncome | -4,060,288 |
| 7 | BaseVar | 3,940,262 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.851 |
| 9 | EconomicCapitalRatio | 2.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
